Clinical Trials Browser

COVID-19, Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic

NCT07204366 2025-10-02

Autoantibodies Against Type I Interferon in Patients Affected With Ph-negative Myeloproliferative Neoplasms (MPN-IFN Study)

Active not recruiting

219 enrolled

Myeloid

COVID-19, Myeloproliferative Disorders

NCT04761822 2025-08-12

SARS

Phase 2 Completed

746 enrolled 28 charts

Myeloid

COVID-19, Hypersensitivity, Mastocytosis, Severe Acute Respiratory Syndrome

NCT06469138 2025-01-29

8479217

Phase 1 Completed

6 enrolled 17 charts

CNSDermatologicGastrointestinalMyeloidOther hematologic neoplasmOther solid neoplasmThoracic

Mesothelioma, Malignant, COVID-19, Carcinoma, Non-Small-Cell Lung, Glioblastoma, Melanoma, Myelodysplastic Syndromes, Pancreatic Neoplasms, Leukemia, Myeloid, Acute

NCT04666025 2024-04-08

SARS-CoV-2 Donor-Recipient Immunity Transfer

Completed

26 enrolled

LymphoidMyeloidOther hematologic neoplasm

COVID-19, Hodgkin Disease, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Primary Myelofibrosis

NCT04416438 2022-10-18

COVIM

Completed

1,793 enrolled

Myeloid

COVID-19, Myeloproliferative Disorders

Clinical Trials

CALPRO

Autoantibodies Against Type I Interferon in Patients Affected With Ph-negative Myeloproliferative Neoplasms (MPN-IFN Study)

SARS

8479217

SARS-CoV-2 Donor-Recipient Immunity Transfer

COVIM